Complete response to crizotinib in a metastatic adenocarcinoma of unknown primary harboring MET amplification and NTRK1 co-occurring mutation
Jing-hao Yao,1 An-sheng Wang,2 Xiao-jing Wang,3,4 Lu Zhang,1 Yue Zhu,1 Yu-rong Ou,5 Zi-shu Wang,1 Yan Yang11Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, People’s Republic of China; 2Department of Thoracic Surgery, The First Affilia...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-05-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/complete-response-to-crizotinib-in-a-metastatic-adenocarcinoma-of-unkn-peer-reviewed-article-OTT |